EN IT

Evommune shares slide 8.1%, but a double bottom keeps the decline in check

Evommune weekly technical analysis: the stock slides 8.1% but carves a clean double bottom in the 12 area with a 23% rebound. The sell signal is in its third week; our swing trading model flags trading as not recommended.

Evommune shares slide 8.1%, but a double bottom keeps the decline in check
US Stocks · Sell Signal
Evommune shares slide 8.1%, but a double bottom keeps the decline in check
July 17, 2026
US Stocks · Sell Signal
Our view last week
Evommune bounces 1.9% after last week's plunge, carving a clean double bottom in the 13 area with a 13% intermediate rebound. In this week's technical analysis the Sell signal loses strength, dropping from 100 to 54 out of 100 — an isolated drop, no new lows — while the setup quality indicator eases to 64 out of 100. Our model flags a fresh short here as high-risk.
This week's summary
Evommune shares slide 8.1% this week, but the daily chart tells a different story: the stock carved a clean double bottom in the 12 area, with a 23% intermediate rebound off the lows. The sell signal is in its third week and the confirmation week closed bearish: discipline calls for holding the position unchanged. Money flow stays deep in distribution and volatility is elevated — a technical picture still jumpy, not one to chase right now.
Sell signal in observation ·3rd week from start ·US stocks ·T2 ★ See Gold version →
IQS Phase
65
in tension
Signal Strength
30
decline starting to make lower lows
Sizing
REDUCED
Ranking
#87 / 140
US stocks sell signals
Trade P&L %
+6.33%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn